William Valle - 16 Jul 2024 Form 4 Insider Report for American Oncology Network, Inc. (AONC)

Reporting relationship: Director
Issuer ticker: AONC
Reported as of: 16 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jul 2024, 16:47:14 UTC
Prior SEC filing: 07 May 2024
Next SEC filing: 31 Jan 2025
Source filing: View source filing
Reporting owner signature: Stephen Spivey, attorney-in-fact

Key filing fact

William Valle filed Form 4 for American Oncology Network, Inc. (AONC) on 18 Jul 2024.

Key facts

This page summarizes William Valle's Form 4 filing for American Oncology Network, Inc. (AONC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Jul 2024, 16:47.

Change

Previous filing in this sequence was filed on 07 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AONC transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +5,000
Change %: +33%
Price: $0.000000
Shares after: 19,981
Date: 16 Jul 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

5,000 shares of Class A Common Stock granted for service as an independent director on the American Oncology Network, Inc. Board of Directors. 3,250 shares will vest on a time-based vesting schedule over four years and 1,750 shares will vest based on a performance-based vesting schedule.